Shkreli himself acknowledged his release with a typically smug Facebook post on Wednesday morning.<\/p>\n\n\n\n
“Getting out of real prison is simpler than getting out of Twitter prison,” he added, referring to his Twitter ban, which he received in 2017 after harassing a female journalist.<\/p>\n\n\n\n
![\"\"](\"https:\/\/americanvoterpolls.com\/wp-content\/uploads\/2022\/05\/Pharma-Bro.png\")
Edmund Sullivan, Shkreli’s acquaintance, is believed to have taken the convicted fraudster from prison. Following the release, he tweeted a photo of the two happy in a car, writing, “I picked up this hitchhiker guy. He claims he’s well-known person as well as hated at the same time.”<\/p>\n\n\n\n Picked up this guy hitchhiking. Says he\u2019s famous. pic.twitter.com\/7XrQaII7lq<\/a><\/p>— Edmund Sullivan (@edmundsullivan) May 18, 2022<\/a><\/blockquote>\n<\/div><\/figure>\n\n\n\n After purchasing the exclusive rights to the anti-parasitic medicine Daraprim in 2015, Shkreli soon became America’s most reviled figure, raising costs from $13.50 per pill to $750 per pill. While in prison, Shkreli was found guilty of illegal monopolistic activity by a federal judge in Manhattan, in addition to his fraud convictions. “Shkreli’s flagrant, purposeful, persistent, long-running, and ultimately dangerous illegal conduct requires imposition of an injunction of this magnitude,” Judge Denise Cote found in her judgement.<\/p>\n","protected":false},"excerpt":{"rendered":"
Daraprim was the sole FDA-approved treatment for toxoplasmosis at the time, a life-threatening illness that can cause major health problems in pregnant women, their newborns, and persons with weakened immune systems due to cancer, HIV\/AIDS, or other conditions. Generic versions of the tablet were finally available in 2020.<\/p>\n\n\n\n
As a result of his conduct, the judge barred Shkreli from the pharmaceutical industry for life<\/a> and ordered him to repay more than $64 million in gains he made by raising the price of Daraprim.<\/p>\n\n\n\n